Correlation Between Europac Gold and Biotechnology Fund

Can any of the company-specific risk be diversified away by investing in both Europac Gold and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Europac Gold and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Europac Gold Fund and Biotechnology Fund Class, you can compare the effects of market volatilities on Europac Gold and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Europac Gold with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Europac Gold and Biotechnology Fund.

Diversification Opportunities for Europac Gold and Biotechnology Fund

0.74

Correlation Coefficient

Europac Gold  Biotechnology Fund

Poor diversification

The 3 months correlation between Europac and BIOTECHNOLOGY is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Europac Gold Fund and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Europac Gold is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Europac Gold Fund are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Europac Gold i.e., Europac Gold and Biotechnology Fund go up and down completely randomly.

Pair Corralation between Europac Gold and Biotechnology Fund

Assuming the 90 days horizon Europac Gold Fund is expected to generate 0.5 times more return on investment than Biotechnology Fund. However, Europac Gold Fund is 1.99 times less risky than Biotechnology Fund. It trades about -0.07 of its potential returns per unit of risk. Biotechnology Fund Class is currently generating about -0.06 per unit of risk. If you would invest  1,046  in Europac Gold Fund on October 10, 2024 and sell it today you would lose (94.00) from holding Europac Gold Fund or give up 8.99% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Europac Gold Fund  vs.  Biotechnology Fund Class

Europac Gold

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Europac Gold Fund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's technical and fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Biotechnology Fund Class

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Pair Trading with Europac Gold and Biotechnology Fund

The main advantage of trading using opposite Europac Gold and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Europac Gold position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.

The idea behind Europac Gold Fund and Biotechnology Fund Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.